Jim Simons Morpho Sys Ag Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.87 - $9.73 $292,326 - $484,554	-49,800 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.08 - $12.45 $16,525 - $22,659	-1,820 Reduced 3.53%	49,800 $469,000
Q3 2021 Nov 12, 2021	BUY	$11.76 - $19.51 $607,051 - $1.01 Million	51,620 New	51,620 $607,000
Q2 2021 Aug 13, 2021	SELL	$18.95 - $23.95 $314,854 - $397,929	-16,615 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$21.56 - $30.66 $358,219 - $509,415	16,615 New	16,615 $362,000

Q3 2020 Nov 13, 2020	SELL	$30.28 - $35.72 $2.44 Million - $2.88 Million	-80,600 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$24.08 - $33.35 $451,909 - $625,879	18,767 Added 30.35%	80,600 $2.55 Million
Q1 2020 May 14, 2020	BUY	$18.86 - $37.36 $729,636 - $1.45 Million	38,687 Added 167.14%	61,833 $1.52 Million
Q4 2019 Feb 13, 2020	SELL	$26.07 - $36.32 $139,578 - $194,457	-5,354 Reduced 18.79%	23,146 $826,000
Q3 2019 Nov 13, 2019	BUY	$24.18 - $31.58 $689,130 - $900,030	28,500 New	28,500 $783,000

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.44B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.